Counselors in Ripon, WI Accepting Medicare

6 Counselors found. Showing 1 - 6

Ashley Lamers, MSE Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 112 Watson St, Ripon, WI 54971 Phone: 920-385-5843    Fax: 920-239-6021

Lindsay A Loewe, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 112 Watson St, Ripon, WI 54971 Phone: 920-896-0189    Fax: 920-694-3021

Kaite Olund Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 112 Watson St., Ripon, WI 54791 Phone: 920-896-0189    Fax: 920-239-6021

Kristi L Sook, LCSW, CSAC Counselor - Addiction (Substance Use Disorder) Medicare: Accepting Medicare Assignments Practice Location: 845 Parkside St, Ripon, WI 54971 Phone: 920-926-4200

Christine Lynn Skoog Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 627 Hillside Ter, Ripon, WI 54971 Phone: 920-266-3633

Amanda Lynn Etlicher Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 14 Arcade Glen Rd, Ripon, WI 54971 Phone: 920-539-0225

News Archive

Study determines role of partial sleep deprivation on energy balance and weight regulation

Evidence linking partial sleep deprivation to energy imbalance is relevant to weight gain prevention and weight loss promotion. A new study published today in the Journal of the Academy of Nutrition and Dietetics bases this finding on an extensive review of literature published over a fifteen-year period.

Toshiba America Medical Systems' Viamo laptop ultrasound system receives FDA clearance

Designed to meet the needs of today's hospitals by combining portability with high-end radiology features, Toshiba America Medical Systems, Inc.'s new ViamoTM laptop ultrasound system has received FDA clearance.

Cleveland Clinic receives two grants to study therapeutic potential of anti-cancer drug in Alzheimer's

The National Institute of Aging, part of the National Institutes of Health, and the Alzheimer's Drug Discovery Foundation awarded five-year grants of $3.2 million and $1.4 million, respectively, to scientists from Cleveland Clinic Lou Ruvo Center for Brain Health to study the therapeutic potential of the anti-cancer drug lenalidomide in early-stage Alzheimer's disease, known as mild cognitive impairment.

Abbott's Humira gains first-line biologic use for psoriasis treatment: Report

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that while Amgen/Stiefel/Pfizer's Enbrel is the most popular biologic across all lines of therapy for psoriasis treatment in newly diagnosed patients, Abbott's Humira is gaining increasing use as a first-line biologic at Enbrel's expense.

Traditional dress protects ethnic girls from emotional problems

New research from Britain suggests that teenage girls from some minority communities who adhere to their family customs have better mental health.

Read more Medical News

› Verified 3 days ago